WELLINGTON MANAGEMENT GROUP LLP - CRINETICS PHARMACEUTICALS IN ownership

CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 95 filers reported holding CRINETICS PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of CRINETICS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$108,260,589
+66.8%
3,640,235
+1.1%
0.02%
+83.3%
Q2 2023$64,902,849
+11.2%
3,601,712
-0.9%
0.01%0.0%
Q1 2023$58,386,547
+13.8%
3,635,526
+29.6%
0.01%
+20.0%
Q4 2022$51,322,076
-0.8%
2,804,485
+6.5%
0.01%
-9.1%
Q3 2022$51,713,000
+52.1%
2,633,011
+44.4%
0.01%
+57.1%
Q2 2022$34,010,000
+50.5%
1,823,598
+77.2%
0.01%
+75.0%
Q1 2022$22,595,000
-25.7%
1,029,364
-3.8%
0.00%
-20.0%
Q4 2021$30,407,000
+58.2%
1,070,272
+17.2%
0.01%
+66.7%
Q3 2021$19,220,000
+36.8%
913,071
+22.5%
0.00%
+50.0%
Q2 2021$14,051,000
+66.5%
745,387
+35.0%
0.00%
+100.0%
Q1 2021$8,437,000
+7.4%
552,167
-0.8%
0.00%0.0%
Q4 2020$7,854,000
+14.5%
556,635
+27.2%
0.00%0.0%
Q3 2020$6,860,000
+25.8%
437,756
+40.6%
0.00%0.0%
Q2 2020$5,453,000311,2810.00%
Other shareholders
CRINETICS PHARMACEUTICALS IN shareholders Q3 2021
NameSharesValueWeighting ↓
Vivo Capital, LLC 3,375,169$76,819,0007.66%
RA Capital Management 1,875,209$42,680,0001.84%
Perceptive Advisors 2,587,953$58,901,0001.66%
EMORY UNIVERSITY 97,035$2,209,0001.55%
New Leaf Venture Partners, L.L.C. 167,700$3,817,0001.05%
Orbimed Advisors 1,914,282$43,569,0000.67%
Opaleye Management Inc. 73,000$1,661,0000.46%
Novo Holdings A/S 135,009$3,073,0000.46%
Virtus ETF Advisers LLC 7,934$181,0000.38%
Eventide Asset Management 384,000$8,740,0000.30%
View complete list of CRINETICS PHARMACEUTICALS IN shareholders